NP / PA
Lindner, Joelle
Lindner, Joelle was paid $667K by Medicaid between Jan 2018 and Dec 2024, across 33 billing codes. Its largest line is 0502F, — 37% of everything it billed.
33Billing provider infoLINDNER, JOELLE
CHICAGO, IL 60612
CHICAGO, IL 60612
33aNPI1245621275assigned 02/12/2015
33bProvider typeFamily Nurse Practitioner
28Total paid$667K
24GClaims16,357
24DCodes billed33
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Nurse Practitioner providers in Illinois
Rank by total paid#37 of 3,353
Median peer was paid$25K
This provider vs. median27×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,491 | $93K | |
| 2019 | 5,541 | $193K | |
| 2020 | 2,108 | $74K | |
| 2021 | 1,899 | $67K | |
| 2022 | 1,620 | $56K | |
| 2023 | 1,704 | $81K | |
| 2024incomplete | 994 | $102K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0502F | 37% | 5,203 | 3,769 | $246K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22% | 1,608 | 1,362 | $149K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 13% | 1,132 | 893 | $89K |
| 59430 | 8.2% | 579 | 469 | $55K | |
| 0500F | 3.7% | 540 | 475 | $25K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 2.1% | 171 | 143 | $14K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.9% | 328 | 303 | $13K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.9% | 328 | 303 | $13K |
| 81025 | 1.6% | 2,158 | 1,794 | $11K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.5% | 771 | 603 | $10K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.1% | 75 | 73 | $7K |
| 90715 | <1% | 190 | 160 | $6K |
21 more codes
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 199 | $6K |
| 90686 | <1% | 262 | $6K | |
| 87808 | <1% | 330 | $5K | |
| H1000 | Prenatal care, at-risk assessment | <1% | 241 | $4K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 55 | $2K |
| 88142 | <1% | 73 | $2K | |
| 81003 | <1% | 581 | $1K | |
| 87205 | <1% | 219 | $1K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 121 | $983.20 |
| 86592 | <1% | 176 | $810.70 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 12 | $447.22 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 17 | $440.37 |
| 96127 | <1% | 27 | $393.16 | |
| 96160 | <1% | 85 | $350.40 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 39 | $338.67 |
| 82950 | <1% | 53 | $266.84 | |
| 86780 | <1% | 18 | $246.57 | |
| 87088 | <1% | 14 | $115.84 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 398 | $39.43 |
| 36415 | Collection of venous blood by venipuncture | <1% | 342 | $36.90 |
| 81002 | <1% | 12 | $31.60 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.